Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 90.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,163 shares of the company’s stock after selling 41,407 shares during the quarter. Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.’s holdings in Procter & Gamble were worth $663,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of PG. Nova Wealth Management Inc. bought a new position in Procter & Gamble in the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC lifted its holdings in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares during the period. Quarry LP acquired a new stake in shares of Procter & Gamble during the 1st quarter worth approximately $33,000. Mizuho Securities Co. Ltd. increased its stake in Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 170 shares during the last quarter. Finally, RMG Wealth Management LLC acquired a new position in Procter & Gamble during the second quarter valued at approximately $37,000. Institutional investors own 65.77% of the company’s stock.
Insider Transactions at Procter & Gamble
In related news, CEO Jon R. Moeller sold 40,119 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the transaction, the chief executive officer directly owned 319,375 shares of the company’s stock, valued at $50,228,106.25. This trade represents a 11.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the transaction, the chief operating officer directly owned 28,036 shares in the company, valued at $4,409,221.72. The trade was a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm’s revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.
Analyst Ratings Changes
A number of equities research analysts have weighed in on PG shares. JPMorgan Chase & Co. reduced their target price on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a report on Friday. Bank of America dropped their price objective on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research report on Wednesday. Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. UBS Group lowered their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Barclays dropped their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $172.21.
Check Out Our Latest Analysis on Procter & Gamble
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Technology Stocks Explained: Here’s What to Know About Tech
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- Using the MarketBeat Dividend Yield Calculator
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- The Basics of Support and Resistance
- Catch the Next Bitcoin Rally With These 3 ETFs
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.